Completion of the combination between Novozymes and Chr. Hansen
January 29, 2024 – Company announcement no. 2 Please see attachment. CONTACT INFORMATION Investor Relations Tobias Cornelius Bjorklund+45 3077 8682tobb@novozymes.com Anders Enevoldsen+45 5350 1453adev@novozymes.comPress Relations Lina Danstrup+45 3077 0552lind@novozymes.com Attachment No. 2 Completion of the combination between Novozymes and Chr. Hansen
Comunicato Precedente
Comunicato Successivo
Please see attachment.
CONTACT INFORMATION
Investor Relations
Tobias Cornelius Bjorklund
+45 3077 8682
tobb@novozymes.com
Anders Enevoldsen
+45 5350 1453
adev@novozymes.com
Press Relations
Lina Danstrup
+45 3077 0552
lind@novozymes.com
Attachment
- No. 2 Completion of the combination between Novozymes and Chr. Hansen
Per maggiori informazioni
Sito Web
chr-hansen.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
;
